Gene regulation by methylation - PubMed
Review
Gene regulation by methylation
Wolf C Mueller et al. Recent Results Cancer Res. 2009.
Abstract
Epigenetic gene regulation of specific genes strongly affects clinical outcome of malignant glioma. MGMT is the best studied gene for the connection of promoter methylation and clinical course in glioblastoma. While MGMT promoter methylation analysis currently does not alter treatment of glioblastoma patients, mainly because of a lack of convincing therapy to radiotherapy and concomitant administration of alkylating drugs, there is increasing interest on the part of patients and physicians in having this molecular parameter assessed. This chapter gives a short overview of the physiological characteristics of the epigenome in normal cells and tissues and the changes in epigenetic gene regulation following malignant transformation. It discusses the technical aspects, advantages, and shortcomings of currently used approaches for single-gene and genome-wide methylation analyses. Finally, an outlook is given on potential therapeutic avenues and targets to overcome tumor-suppressor gene silencing by aberrant promoter methylation in gliomas.
Similar articles
-
Sasai K, Nodagashira M, Nishihara H, Aoyanagi E, Wang L, Katoh M, Murata J, Ozaki Y, Ito T, Fujimoto S, Kaneko S, Nagashima K, Tanaka S. Sasai K, et al. Am J Surg Pathol. 2008 Aug;32(8):1220-7. doi: 10.1097/PAS.0b013e318164c3f0. Am J Surg Pathol. 2008. PMID: 18580490
-
Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR, Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J. Shamsara J, et al. Cancer Invest. 2009 Oct;27(8):825-9. doi: 10.1080/07357900902783211. Cancer Invest. 2009. PMID: 19544111
-
Malley DS, Hamoudi RA, Kocialkowski S, Pearson DM, Collins VP, Ichimura K. Malley DS, et al. Acta Neuropathol. 2011 May;121(5):651-61. doi: 10.1007/s00401-011-0803-5. Epub 2011 Feb 3. Acta Neuropathol. 2011. PMID: 21287394
-
[Strategy for studying gene methylation: the example of MGMT].
Fina F, Nanni-Metellus I, Courdy C, Figarella-Branger D, Martin PM, Ouafik L. Fina F, et al. Ann Pathol. 2009 Nov;29 Spec No 1:S37-9. doi: 10.1016/j.annpat.2009.07.015. Epub 2009 Oct 6. Ann Pathol. 2009. PMID: 19887248 Review. French. No abstract available.
-
Epigenetic aberrations and therapeutic implications in gliomas.
Natsume A, Kondo Y, Ito M, Motomura K, Wakabayashi T, Yoshida J. Natsume A, et al. Cancer Sci. 2010 Jun;101(6):1331-6. doi: 10.1111/j.1349-7006.2010.01545.x. Epub 2010 Mar 15. Cancer Sci. 2010. PMID: 20384628 Free PMC article. Review.
Cited by
-
Shumay E, Fowler JS. Shumay E, et al. Epigenetics. 2010 May 16;5(4):325-42. doi: 10.4161/epi.5.4.11719. Epub 2010 May 5. Epigenetics. 2010. PMID: 20421737 Free PMC article.
-
Hu X, Zhao D, Strotmann A. Hu X, et al. PLoS One. 2013 Jun 25;8(6):e67121. doi: 10.1371/journal.pone.0067121. Print 2013. PLoS One. 2013. PMID: 23825632 Free PMC article.
-
Mechanisms of hemorrhagic cystitis.
Haldar S, Dru C, Bhowmick NA. Haldar S, et al. Am J Clin Exp Urol. 2014 Oct 2;2(3):199-208. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25374922 Free PMC article. Review.
-
TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H2S System.
Peng J, Tang ZH, Ren Z, He B, Zeng Y, Liu LS, Wang Z, Wei DH, Zheng XL, Jiang ZS. Peng J, et al. Front Pharmacol. 2017 Jul 26;8:486. doi: 10.3389/fphar.2017.00486. eCollection 2017. Front Pharmacol. 2017. PMID: 28798687 Free PMC article.
-
Genetic markers in oligodendroglial tumours.
Velnar T, Smrdel U, Popovic M, Bunc G. Velnar T, et al. Radiol Oncol. 2010 Mar;44(1):13-8. doi: 10.2478/v10019-010-0007-y. Epub 2010 Mar 18. Radiol Oncol. 2010. PMID: 22933885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials